Sara Nik

Stock Analyst at HC Wainwright & Co.

(4.00)

# 433

Out of 5,182 analysts

7

Total ratings

45.45%

Success rate

35.74%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KTTA Pasithea Therapeutics	Reiterates: Buy	$3	$0.69	+334.78%	2	Apr 20, 2026
	MBRX Moleculin Biotech	Reiterates: Buy	$22	$2.54	+766.14%	4	Mar 24, 2026
	CRIS Curis	Reiterates: Buy	$17	$0.58	+2,822.97%	1	Mar 20, 2026

Pasithea Therapeutics

Apr 20, 2026

Reiterates: Buy

Price Target: $3

Current: $0.69

Upside: +334.78%

Moleculin Biotech

Mar 24, 2026

Reiterates: Buy

Price Target: $22

Current: $2.54

Upside: +766.14%

Curis

Mar 20, 2026

Reiterates: Buy

Price Target: $17

Current: $0.58

Upside: +2,822.97%